SEC Comment Letter for ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221) (ARTL) — Mar 27, 2018
ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221)
Date: March 27, 2018 · CIK: 0001621221 · Accession: 0000000000-18-009250
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 3561 March 26, 2018 Gregory Gorgas Chief Executive Officer Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla, CA 92037
Re: Artelo Biosciences, Inc. Form 10-K for Fiscal Year Ended August 31, 2017 Filed November 29, 2017 File No. 333 -199213
Dear Mr. Gorgas:
We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosure s, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ James Allegretto
Show Raw Text
Mail Stop 3561 March 26, 2018 Gregory Gorgas Chief Executive Officer Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla, CA 92037 Re: Artelo Biosciences, Inc. Form 10-K for Fiscal Year Ended August 31, 2017 Filed November 29, 2017 File No. 333 -199213 Dear Mr. Gorgas: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosure s, notwithstanding any review, comments, action or absence of action by the staff . Sincerely, /s/ James Allegretto James Allegretto Senior Assistant Chief Accountant Office of Consumer Products cc: Marty Waters, Esq. Wilson Sonsini Goodrich & Rosati PC